John Slump (08BBA)
Chief Financial Officer, Surgical Innovation Associates and EDGe Surgical

Slump launched his career as an entrepreneur and Chief Financial Officer (CFO) as a student at the University of Iowa by co-founding Corvida Medical with Jared Garfield (09BBA) in 2008. They started the company after Slump’s sister was diagnosed with cancer, and they realized health care workers handling chemotherapy medications were suffering from serious health consequences from toxic exposure to the drugs. He served as CFO for more than a decade, raised $35 million in funding, and sold a majority interest to private equity investors who more recently did a deal with Fresenius Kabi.

From 2011-15, Slump contemporaneously served as co-founder and board member at Farapulse Inc. (formerly Iowa Approach). There, he worked with University of Iowa Assistant Professor of Internal and Cardiovascular Medicine Steven Mickelsen, MD, to negotiate a license agreement with UIRF and to raise millions of dollars in investment capital to further develop Mickelsen’s novel approach to treating atrial fibrillation, the world’s most common form of irregular heart rhythm. Boston Scientific (NYSE: BSX) acquired Farapulse in a deal valued at more than $400 million earlier this year.

Slump joined SIA in 2018 and has raised $16 million in private investment and National Cancer Institute funding for an implantable device aimed at helping mastectomy patients. In September 2020, Slump also joined EDGe Surgical, a medical device company focused on orthopedic surgery instrumentation. Slump continues to serve as CFO of both emerging growth medical device corporations.

VISIT EDGe SURGICAL